Infliximab for severe gastrointestinal bleeding in Crohn's disease.
Ando
Yugo
Y
Matsushita
Mitsunobu
M
Kawamata
Seiji
S
Shimatani
Masaaki
M
Fujii
Toshihito
T
Okazaki
Kazuichi
K
D000293:Adolescent; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use*; D003113:Colonoscopy; D003424:Crohn Disease / Q000150:complications* / Q000175:diagnosis; D005260:Female; D005500:Follow-Up Studies; D005765:Gastrointestinal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D006471:Gastrointestinal Hemorrhage / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D000069285:Infliximab; D007262:Infusions, Intravenous; D012720:Severity of Illness Index
D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D000069285:Infliximab